NAC

NAC by Xymogen

N-acetyl-l-cysteine (NAC) by Xymogen is an amino acid supplement that provides L-cysteine, which is crucial for the tripeptide glutathione.* Its effects may be visible in anti-oxidation, which should improve after taking this product.*

Who May Consider NAC by Xymogen?

NAC by Xymogen may support your health if you:

• seek anti-oxidant support*
• have respiratory concerns*
• experience a lot of stress*

How May n-acetyl-l-cysteine (nac) by Xymogen Affect Your Health?

Xymogen’s NAC may have the following health benefits:

• supporting glutathione synthesis*
• promoting anti-oxidant activity in all body cells*
• supporting respiratory function*
• supporting immunity*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about this supplement.

Recommendation:
Take one to two capsules twice daily between meals, or as directed by your healthcare practitioner.

Serving Size: 2 Capsules
Servings Per Container: 30 or 60

Amount Per Serving:
N-Acetyl-L-Cysteine 1.2 g

Other Ingredients: HPMC (capsule), stearic acid, magnesium stearate, and silica.

Does Not Contain: Wheat, gluten, corn, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.

Caution: Individuals taking medication should discuss potential interactions with their healthcare practitioner. Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach of children.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Click here to view Data Sheet

LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518

References:

1. Krinsky, D. L., LaValle, J. B., Hawkins, E. B., & et al. (2003). Natural therapeutics pocket guide (2nd ed.). Lexi-Comp.
2. Grandjean, E. M., Berthet, P., Ruffmann, R., & Leuenberger, P. (2000). Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: A meta-analysis of published double-blind, placebo-controlled clinical trials. Clinical Therapeutics, 22(2), 209-221. https://doi.org/10.1016/S0149-2918(00)80005-5
3. Yalçin, E., Altin, F., Cinhüseyinoglu, F., & et al. (2002). N-acetylcysteine in chronic blepharitis. Cornea, 21(2), 164-168. https://doi.org/10.1097/00003226-200203000-00009
4. Ottenwalder, H., & Simon, P. (1987). Differential effect of N-acetylcysteine on excretion of the metals Hg, Cd, Pb and Au. Archives of Toxicology, 60(5), 401-402. https://doi.org/10.1007/BF00314782
5. Keogh, J. P., Steffen, B., & Siegers, C. P. (1994). Cytotoxicity of heavy metals in the human small intestinal epithelial cell line I-407: The role of glutathione. Journal of Toxicology and Environmental Health, 43(3), 351-359. https://doi.org/10.1080/009841094160956
6. Witschi, A., & et al. (1992). The systemic availability of oral glutathione. European Journal of Clinical Pharmacology, 43, 667-669. https://doi.org/10.1007/BF00187204
7. De Rosa, S. C., & et al. (2000). N-acetylcysteine replenishes glutathione in HIV infection. European Journal of Clinical Investigation, 30(10), 841-842. https://doi.org/10.1046/j.1365-2362.2000.00799.x
8. Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & et al. (2007). N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency. Current Opinion in Pharmacology, 7(4), 355-359. https://doi.org/10.1016/j.coph.2007.05.001
9. White, A.C., Thannickal, V.J., & Fanburg, B.L.(1994). Glutathione deficiency in human disease.Journal of Nutritional Biochemistry, 5, 218-226.http://www.sciencedirect.com/science/article/pii/0955286394900396
10. Pace, G.W., & Leaf C.D.(1995). The role of oxidative stress in HIV disease.Free Radical Biology and Medicine, 19, 523-528.http://doi.org/10.1016/0891-5849(95)00053-A
11. Favier, A., Sappey, C., Leclerc, P., & et al.(1994). Antioxidant status and lipid peroxidation in patients infected with HIV.Chemical Biology Interactions, 91(2-3),165-180.http://doi.org/10.1016/0009-2797(94)90092-X
12. Nakamura, H., Masutani, H., & Yodoi J.(2002). Redox imbalance and its control in HIV infection.Antioxidants and Redox Signaling, 4(3),455-464.http://doi.org/10.1089/152308602320263580

13.Roberts R.L., Aroda V.R., Ank B.J.(1995). N-acetylcysteine enhances antibody-dependent cellular toxicity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients.Journal of Infectious Diseases,172(6),1492-1502.http://doi.org/10.1093/infdis/172.6.1492

14.Hu H.L., Forsey R.J., Blades T.J., & et al.(2000). Antioxidants may contribute in the fight against ageing: An in vitro model.Mechanisms of Ageing and Development,121(1-3),217-230.http://doi.org/10.1016/S0047-6374(00)00155-X